PATENT CLAIM ANALYSIS

Application Number: 16151126
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "738000"]

Abstract:
The present invention provides compositions and methods of their use in treating muscular dystrophy and other disorders.

Claim (Index 1):
A method of treating muscular dystrophy that is not associated with a defect in glycosylation of \u03b1-DG in a subject, comprising administering to the subject an effective amount of a CDP-ribitol, thereby treating the muscular dystrophy that is not associated with a defect in glycosylation of \u03b1-DG in the subject.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16151113', '15842580', '16112447', '16151137', '15880283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8247268745170759
- 35 USC 102 Novelty (BERT): 0.6021066785545771
- Combined Prediction Score: 0.8024648549208261
- Mean Citation Score: 586.9506299999998
- Max Citation Score: 642.9541
- Similarity Product: 427.7160579619646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test